Timeline
Crism Therapeutics shares rose after FDA Orphan Drug Designation
CRISM Therapeutics lands UK grant for Phase 2 glioblastoma trial
The Premarket Brief: CMC Markets income targets, CRISM grant boost, Helium One, Safestay, S4 Capital, Angus Energy, and more
CRISM Therapeutics lands Northern Ireland grant for ChemoSeed prostate programme
Health & Bio Today: Genedrive chairman exits as Nugent joins board, Novo Nordisk, Crism, Diaceutics, CVS Group, AstraZeneca,
CRISM Therapeutics launches retail offer to raise up to £100,000
CRISM Therapeutics raises £2.5m to fund Phase 2 trial and grant pursuit
The Premarket Brief: Associated British Foods, Griffin Mining, British Land, Gear4music, Crest Nicholson, Intercede Group ...
CRISM Therapeutics shows 58% tumour reduction with Docetaxel-ChemoSeed
More in Telecoms
Vodafone Group shares soar after stake sale to Xavier Niel
French billionaire Xavier Niel is investing in Vodafone Group via his Vega entity, with funding provided entirely by Niel personally and financial institutions.